SATO, H., FUSHIMI, C., OKADA, T., MATSUKI, T., KONDO, T., OMURA, G., . . . TSUKAHARA, K. (2020). Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma. In Vivo.
Citação norma ChicagoSATO, HIROKI, et al. "Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma." In Vivo 2020.
MLA citiranjeSATO, HIROKI, et al. "Investigation of the Efficacy and Safety of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma." In Vivo 2020.
Opozorilo: Ti citati niso vedno 100% točni.